Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
$3.33
+2.5%
$3.56
$1.65
$6.97
$55.45M0.3769,876 shs38,528 shs
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
$0.01
$0.03
$0.00
$1.27
$806K0.2826,719 shsN/A
ImmuCell Co. stock logo
ICCC
ImmuCell
$5.03
+0.6%
$5.15
$4.26
$6.05
$39.12M0.67,989 shs5,994 shs
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
$10.42
+1.2%
$11.53
$7.80
$20.65
$3.01B4.1926.69 million shs22.24 million shs
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
$1.80
+7.1%
$2.02
$1.66
$5.50
$13.73M1.2473,716 shs13,876 shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
+2.46%+17.25%+48.00%+2,278.57%+81.97%
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
0.00%-68.00%-68.00%-57.33%-79.78%
ImmuCell Co. stock logo
ICCC
ImmuCell
+0.60%-2.14%-3.82%-3.73%+2.65%
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
+1.17%-12.66%+1.26%-7.05%-2.98%
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
+7.27%-1.52%-11.16%-39.93%-64.40%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
ImmuCell Co. stock logo
ICCC
ImmuCell
N/AN/AN/AN/AN/AN/AN/AN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
3.4786 of 5 stars
4.52.00.00.01.51.71.9
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
0.4731 of 5 stars
0.03.00.00.02.41.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
N/AN/AN/AN/A
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
N/AN/AN/AN/A
ImmuCell Co. stock logo
ICCC
ImmuCell
N/AN/AN/AN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
3.00
Buy$18.4276.76% Upside
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
N/AN/AN/AN/A

Current Analyst Ratings

Latest RIOT, TRIB, ICCC, AKER, and GNWSF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
5/1/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$20.00 ➝ $17.00
4/22/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
4/22/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$17.00
4/10/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$15.00 ➝ $15.50
4/5/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $16.00
4/1/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
ATB Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$20.00
3/28/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$20.00
3/20/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$15.00
3/18/2024
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$18.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
$1.58M35.10N/AN/A$5.38 per share0.62
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
$4.15M0.19N/AN/A($0.02) per share-0.64
ImmuCell Co. stock logo
ICCC
ImmuCell
$17.47M2.25N/AN/A$3.23 per share1.56
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
$280.70M10.72$1.04 per share10.00$9.14 per share1.14
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
$56.83M0.24N/AN/A($3.14) per share-0.57

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
-$3.89MN/A0.00N/AN/A-87.42%-73.31%N/A
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
-$6.86M-$0.28N/AN/A-200.26%N/A-165.13%N/A
ImmuCell Co. stock logo
ICCC
ImmuCell
-$5.78M-$0.75N/AN/A-33.05%-21.79%-13.16%5/9/2024 (Confirmed)
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
-$49.47M$0.8711.9845.30N/A76.02%14.63%13.44%8/14/2024 (Estimated)
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
-$24.02M-$3.17N/A3.60N/A-42.26%N/A-36.02%7/4/2024 (Estimated)

Latest RIOT, TRIB, ICCC, AKER, and GNWSF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
ImmuCell Co. stock logo
ICCC
ImmuCell
N/AN/AN/AN/AN/AN/A  
4/4/2024Q4 2023
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
N/A-$0.68-$0.68-$0.64N/A$13.43 million
2/27/2024Q4 2023
ImmuCell Co. stock logo
ICCC
ImmuCell
N/A-$0.15-$0.15-$0.15N/A$5.10 million
2/22/2024Q4 2023
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
-$0.29$0.48+$0.77$0.48$84.94 million$78.83 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
N/AN/AN/AN/AN/A
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
N/AN/AN/AN/AN/A
ImmuCell Co. stock logo
ICCC
ImmuCell
N/AN/AN/AN/AN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
N/AN/AN/AN/AN/A
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
N/A
9.22
9.22
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
N/A
1.15
1.08
ImmuCell Co. stock logo
ICCC
ImmuCell
0.42
2.73
0.87
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
N/A
8.33
8.33
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
N/A
2.60
1.27

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
5.52%
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
0.02%
ImmuCell Co. stock logo
ICCC
ImmuCell
13.47%
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
40.27%
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
78.97%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Akers Biosciences, Inc. stock logo
AKER
Akers Biosciences
416.65 millionN/ANot Optionable
StageZero Life Sciences Ltd. stock logo
GNWSF
StageZero Life Sciences
5163.00 millionN/ANot Optionable
ImmuCell Co. stock logo
ICCC
ImmuCell
747.82 million7.33 millionNot Optionable
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
534288.79 million276.08 millionOptionable
Trinity Biotech plc stock logo
TRIB
Trinity Biotech
3987.62 million7.00 millionOptionable

RIOT, TRIB, ICCC, AKER, and GNWSF Headlines

SourceHeadline
Trinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.comTrinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.com
americanbankingnews.com - May 2 at 5:14 AM
Trinity Biotech plc (TRIB)Trinity Biotech plc (TRIB)
finance.yahoo.com - May 1 at 2:45 AM
A new South Bend golf power? Tiny Trinity tops Penn by 7 shots to win Morris Park InvitationalA new South Bend golf power? Tiny Trinity tops Penn by 7 shots to win Morris Park Invitational
msn.com - April 29 at 3:10 PM
Cougars hosted annual Trinity Invite on SaturdayCougars hosted annual Trinity Invite on Saturday
tribtown.com - April 29 at 3:10 PM
Short Interest in Trinity Biotech plc (NASDAQ:TRIB) Grows By 58.3%Short Interest in Trinity Biotech plc (NASDAQ:TRIB) Grows By 58.3%
americanbankingnews.com - April 29 at 5:40 AM
New area power tiny Trinity edges Penn by seven strokes to win Morris Park InvitationalNew area power tiny Trinity edges Penn by seven strokes to win Morris Park Invitational
msn.com - April 27 at 5:30 AM
Mental health crisis at the hospital’s door | Philly Health InsiderMental health crisis at the hospital’s door | Philly Health Insider
msn.com - April 27 at 12:30 AM
Trinity Biotech is seeking biosensor techs for Bray as it closes Kansas plantTrinity Biotech is seeking biosensor techs for Bray as it closes Kansas plant
independent.ie - April 20 at 10:28 PM
Trinity held annual boys’ basketball banquet on SundayTrinity held annual boys’ basketball banquet on Sunday
tribtown.com - April 9 at 10:49 PM
Trinity Biotech will shutter Kansas City manufacturing plantTrinity Biotech will shutter Kansas City manufacturing plant
bizjournals.com - April 8 at 4:42 PM
Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call TranscriptTrinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 8 at 9:26 AM
Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse into ...
finance.yahoo.com - April 5 at 6:04 PM
TRIB Stock Earnings: Trinity Biotech Misses EPS, Misses Revenue for Q4 2023TRIB Stock Earnings: Trinity Biotech Misses EPS, Misses Revenue for Q4 2023
investorplace.com - April 4 at 2:06 PM
Trinity Biotech plc: Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business UpdatesTrinity Biotech plc: Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
finanznachrichten.de - April 4 at 10:09 AM
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business UpdatesTrinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
globenewswire.com - April 4 at 7:30 AM
What Wall Street expects from Trinity Biotechs earningsWhat Wall Street expects from Trinity Biotech's earnings
markets.businessinsider.com - April 3 at 9:55 AM
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial ResultsTrinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
globenewswire.com - March 28 at 6:39 PM
Trinity Hunt’s Supreme Group Names Veteran Exec as CEOTrinity Hunt’s Supreme Group Names Veteran Exec as CEO
dallasinnovates.com - March 23 at 12:53 AM
Biotech firms triples footprint in Frederick for smallpox therapeutic clinical trialsBiotech firms triples footprint in Frederick for smallpox therapeutic clinical trials
fredericknewspost.com - March 21 at 10:39 PM
European Equities Traded in the US as American Depositary Receipts Ease WednesdayEuropean Equities Traded in the US as American Depositary Receipts Ease Wednesday
msn.com - March 20 at 11:30 AM
San Diego’s latest biotech, Contineum Therapeutics, files to go publicSan Diego’s latest biotech, Contineum Therapeutics, files to go public
msn.com - March 18 at 8:08 PM
Trinity men advance to the Division III Final Four after 69-62 win over CalvinTrinity men advance to the Division III Final Four after 69-62 win over Calvin
courant.com - March 10 at 12:48 AM
Trinity Biotech plc: Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleTrinity Biotech plc: Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
finanznachrichten.de - March 8 at 2:07 PM
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleTrinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
globenewswire.com - March 8 at 10:03 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Akers Biosciences logo

Akers Biosciences

NASDAQ:AKER
Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York.
StageZero Life Sciences logo

StageZero Life Sciences

OTCMKTS:GNWSF
StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.
ImmuCell logo

ImmuCell

NASDAQ:ICCC
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Riot Platforms logo

Riot Platforms

NASDAQ:RIOT
Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. The company operates through three segments: Bitcoin Mining, Data Center Hosting, and Engineering. It also provides co-location services for institutional-scale bitcoin mining companies; critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners; operation of data centers; and maintenance/management of computing capacity. In addition, the company engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; and electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial, and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.
Trinity Biotech logo

Trinity Biotech

NASDAQ:TRIB
Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.